Enteric coating of mycophenolate sodium: A rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate

被引：59

作者：

Bjarnason, I ^{[1
]}

机构：

[1] Guys Kings & St Thomas Med Sch, London SE5 9PJ, England

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期

关键词：

D O I：

10.1016/S0041-1345(01)02377-6

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：3238 / 3240

页数：3

共 21 条

[1] GASTRODUODENAL LESIONS ASSOCIATED WITH 2 DIFFERENT PIROXICAM FORMULATIONS - AN ENDOSCOPIC COMPARISON [J].

AABAKKEN, L ;

OLAUSSEN, B ;

MOWINCKEL, P ;

OSNES, M .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (12) :1049-1054

[2] BIOAVAILABILITY OF INDOMETHACIN FROM 2 MULTIPLE-UNITS CONTROLLED-RELEASE FORMULATIONS [J].

BECHGAARD, H ;

BRODIE, RR ;

CHASSEAUD, LF ;

HOUMOLLER, P ;

HUNTER, JO ;

SIKLOS, P ;

TAYLOR, T .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (06) :511-515

[3]

BJARNASON I, 1993, GASTROENTEROLOGY, V105, P1590, DOI 10.1016/0016-5085(93)90186-G

[4]

Bjarnason I, 1996, ITAL J GASTROENTEROL, V28, P19

[5]

CALDWELL JR, 1994, J RHEUMATOL, V21, P689

[6]

Dammann HG, 1999, ALIMENT PHARM THER, V13, P1109

[7] Cytomegalovirus infection and abdominal pain with mycophenolate mofetil - Is there a link? [J].

Gallaher, H ;

Andrews, PSA .

DRUG SAFETY, 2001, 24 (06) :405-412

[8]

GRINYO J, 1995, LANCET, V345, P1321

[9] The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation [J].

Hale, MD ;

Nicholls, AJ ;

Bullingham, RES ;

Hené, R ;

Hoitsma, A ;

Squifflet, JP ;

Weimar, W ;

Vanrenterghem, Y ;

Van de Woude, FJ ;

Verpooten, GA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (06) :672-683

[10] ASPIRIN-INDUCED GASTRIC-MUCOSAL DAMAGE - PREVENTION BY ENTERIC-COATING AND RELATION TO PROSTAGLANDIN SYNTHESIS [J].

HAWTHORNE, AB ;

MAHIDA, YR ;

COLE, AT ;

HAWKEY, CJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) :77-83

← 1 2 3 →